Mumbai

Micro Labs, one of the fastest growing pharmaceutical companies in India with Global operations in over 60 countries. We enjoy a strong presence in various segments like Cardiology, Opthalmology, Psychiatry, Dermatology, Diabetology etc. with most of its brands among TOP 5 in their respective category.

Shreya Group has interests in both pharmaceutical and biopharmaceutical products in key therapeutic segments. Currently, Shreya operates in Russia, CIS, India, South East Asia and African countries. The Group turnover for the year 2006 was US $ 581 million including US $ 85 million in India.

Amoli has a successful track record in the pharmaceutical and allied industry. Making a beginning as a manufacturer of API’s and Intermediates, it made successful forays in the field of ‘Contract Research’ and ‘Custom Synthesis’. Amoli has been working collaboratively with some of the leading global healthcare players.

Post: Sales Coordinator

Umedica Laboratories Ltd.  is part of a Amoli Group of Companies, manufacturing and exporting a wide range of Injectables, tablets, capsules, suspensions, dry syrups in the categories of non-steriodal anti-inflammatory (NSAIDs), antibiotics, antifungal, analgesics, antiviral, antituberculosis agents, antihistamines, psychotropics and multivitamins etc.

CALYX is an US FDA inspected Active Pharmaceutical Ingredient manufacturer with excellent custom synthesis capabilities. Corporate head quarter is located in the commercial hub of India – Mumbai with its manufacturing facilities on the outskirts of Mumbai.

Flamingo Pharmaceuticals Ltd. is a quality driven pharmaceutical company with an experience of over two decades in global markets, exporting to 52 countries and having Rs.200 crores+ turnover. Flamingo has WHO-GMP/UK MHRA certified 100% EOU unit.

Cactus Communications—a company dedicated to the pursuit of good English. We provide editing, educational, transcription, and training services to individual and institutional clients worldwide. All our businesses are linked together by one common factor—great written English.